Accidents vasculaires cérébraux

Thérapeutique

Available
Shipped to France : 0.01€
(for any order > 35€)

Partie 1. Organisation de la prise en charge de l'accident vasculaire cérébral 48,00 €
838.34KB
Partie 2. Phase aiguë de l'accident vasculaire cérébral 48,00 €
5.26MB
Partie 3. Prévention de l'accident vasculaire cérébral 48,00 €
7.11MB
Partie 4. Aspects particulier de l'accident vasculaire cérébral 48,00 €
4.50MB
Partie 5. Après l'AVC 48,00 €
1.29MB
Collection: Traité de neurologie
Publisher: DOIN
Pages: 672
Format: 17 x 24 cm
ISBN : 978-2-7040-1583-2
ISBN élec : 978-2-7040-1599-3
Printed in: French
Publication date: 25/04/2018

• With 140,000 new cases each year in France (one every 4 minutes), strokes are the leading cause of death in women, the third in men, the leading cause of acquired physical disability in adults, and the 2nd cause of dementia.


• Strokes are a heterogeneous group of diseases requiring various treatments. These need to be adapted to the different types of stroke, and, for each type of stroke, to many different causes. There may be several treatment options for each of these causes.

Major therapeutic advances have been made in recent years, whether in the organization of care, acute treatment or prevention.

• Focusing on the therapeutic point of view, this book reviews the most recent advances in the management of these diseases which are a real public health issue.


Short summary

Part 1. Organization of stroke management

Part 2. Acute phase

Part 3. Stroke prevention

Part 4. After the stroke


Les coordonnateurs :

Pr Jean-Louis Mas, Chef de service de neurologie, Centre hospitalier Sainte-Anne, Paris ; Professeur de neurologie à l’Université Paris-Descartes ; Président de la Fondation pour la recherche sur les AVC

Pr Didier Leys, Chef du service de neurologie, CHU de Lille ; Professeur de neurologie à l’Université Lille-2 ; Membre correspondant de l’Académie nationale de médecine

We recommand

Dementia

Bruno Dubois, Agnès Michon

The reference book about Alzheimer’s disease and neurological diseases with cognitive and behavioural expression.